Is CHEMOPH.BO stock in a buyable oversold bounce setup now?

Yes, the intraday rebound to **INR 130.85** on 26 Feb 2026 suggests a tactical oversold bounce. Consider a scaled entry above **INR 122.00**, target **INR 144.37**, and use a stop below **INR 112.00**. Adjust size for liquidity and risk.

What are the key valuation metrics for CHEMOPH.BO stock?

Key metrics: market cap **INR 196,275,000.00**, EPS **-81.48**, PE **-1.61**, book value **INR 87.63**, and price-to-book **1.49**. These show mixed valuation and require cautious interpretation.

What does Meyka AI forecast for CHEMOPH.BO stock?

Meyka AI's forecast model projects a quarterly level of **INR 144.37** and a yearly level of **INR 182.48**. The quarterly upside from **INR 130.85** is **10.33%**. Forecasts are model-based projections and not guarantees.

What are the main risks to an oversold bounce trade in CHEMOPH.BO stock?

Main risks: negative earnings, thin liquidity (volume **766.00**), and margins under pressure. Large orders can move price. Use tight stops, small position sizes, and watch company announcements.

IN Stocks

INR 130.85 CHEMOPH.BO Chemo Pharma (BSE) 26 Feb 2026: oversold bounce watch

ByHuzaifa Zahoor February 26, 2026February 26, 2026

We saw a strong intraday recovery in CHEMOPH.BO stock on 26 Feb 2026, closing at INR 130.85 on the BSE after touching a session low of INR 115.00. The jump of INR 24.62 on the day and relative volume at 1.49x versus average suggests a short-term oversold bounce. We view this as a tactical rebound, not a trend reversal. Traders should watch immediate resistance and the company’s fundamentals before adding size.